IL97399A0 - Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same - Google Patents

Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same

Info

Publication number
IL97399A0
IL97399A0 IL97399A IL9739991A IL97399A0 IL 97399 A0 IL97399 A0 IL 97399A0 IL 97399 A IL97399 A IL 97399A IL 9739991 A IL9739991 A IL 9739991A IL 97399 A0 IL97399 A0 IL 97399A0
Authority
IL
Israel
Prior art keywords
cloning
production
methods
binding domain
same
Prior art date
Application number
IL97399A
Other languages
English (en)
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of IL97399A0 publication Critical patent/IL97399A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL97399A 1990-03-02 1991-03-03 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same IL97399A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48776790A 1990-03-02 1990-03-02

Publications (1)

Publication Number Publication Date
IL97399A0 true IL97399A0 (en) 1992-06-21

Family

ID=23937035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97399A IL97399A0 (en) 1990-03-02 1991-03-03 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same

Country Status (10)

Country Link
EP (1) EP0517826A4 (xx)
JP (1) JPH05506646A (xx)
CA (1) CA2077446A1 (xx)
FI (1) FI923935A0 (xx)
HU (1) HU216066B (xx)
IL (1) IL97399A0 (xx)
NO (1) NO923410L (xx)
NZ (1) NZ237244A (xx)
RU (1) RU2109816C1 (xx)
WO (1) WO1991013093A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900476A (en) * 1986-05-30 1999-05-04 The Scripps Research Institute Therapeutic domains of van Willebrand factor
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
FR2686901A1 (fr) * 1992-01-31 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant.
AU6169294A (en) * 1993-02-11 1994-08-29 Du Pont Merck Pharmaceutical Company, The 15-oxasterols as hypocholesterolemics
IL109383A0 (en) * 1993-04-23 1994-07-31 Bio Technology General Corp Method for enhancing thrombolysis
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT408443B (de) * 1998-02-27 2001-11-26 Immuno Ag Verfahren zur gewinnung von gereinigtem faktor viii:c/vwf-komplex
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
EP2438169B1 (en) * 2009-06-03 2017-08-09 Tobira Therapeutics, Inc. Nucleic acid modulators of glycoprotein vi
GB201707139D0 (en) 2017-05-04 2017-06-21 Imp Innovations Ltd Polypeptides
CN110624105B (zh) * 2019-09-24 2021-06-11 苏州大学 血管性血友病因子的结构敏感多肽抗原的序列

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
EP0255206B1 (en) * 1986-05-30 1995-03-22 The Scripps Research Institute Peptides that inhibit von Willebrand factor binding

Also Published As

Publication number Publication date
FI923935A (fi) 1992-09-02
NZ237244A (en) 1992-10-28
EP0517826A4 (en) 1993-05-26
HUT63183A (en) 1993-07-28
RU2109816C1 (ru) 1998-04-27
AU7496491A (en) 1991-09-18
WO1991013093A1 (en) 1991-09-05
HU9202821D0 (en) 1992-11-30
CA2077446A1 (en) 1991-09-03
AU645077B2 (en) 1994-01-06
FI923935A0 (fi) 1992-09-02
NO923410L (no) 1992-10-26
NO923410D0 (no) 1992-09-01
JPH05506646A (ja) 1993-09-30
HU216066B (hu) 1999-04-28
EP0517826A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
DE68928033D1 (de) Stereosynthesizer und entsprechendes verfahren
EP0455185A3 (en) Hair-treating microemulsion composition and method of preparing and using the same
DK659589A (da) Fedtstofsammensaetning og levnedsmiddel omfattende samme
GB2243956B (en) Electrical resistors and methods of making same
EP0517826A4 (en) Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same
DE59302386D1 (de) Verwendung von polykondensaten und neue polykondensate
DE4393944T1 (de) Verwendung von Ecdysteroiden in der Kosmetik und Dermatologie
GB9013410D0 (en) Polypeptide and its use
DE69214283D1 (de) Verwendung von cellulase bei der zellstoffbehandlung
RO105577B1 (ro) Compozitie poliolefinica plastomerica si procedeu de obtinere a acesteia
IL93857A0 (en) Substituted isoquinolines and methods of using same
IL88308A0 (en) Peptides that block the binding of von willebrand factor
DK62589D0 (da) Kloning og ekspression af human vaekstfaktor
PL288761A1 (en) Method of obtaining novel polypeptides
AU2645588A (en) The von willebrand factor binding domain of factor viii
IL83347A0 (en) Recombinant htlv-iii proteins and their use
ZA917009B (en) Polyethylene terephthalate compositions and methods of using thereof
DE69524590T2 (de) Zusammensetzung von 5htida und 5htid antagonisten
EP0473419A3 (en) Voltage non-linear resistor and method of producing the same
IL88880A (en) Preparation of halopyridine intermediates and some such novel compounds
ATA140688A (de) Neue 5-methoxyalkylammoniumtetrahydrofurane und -tetrahydrothiophene
NO914919L (no) Nikkelbasert superlegering og anvendelse av denne
EP0459788A3 (en) Modified proteins and methods of producing same
DK299889D0 (da) Kloning og ekspression af human vaevsfaktor
EP0407543A4 (en) Mammalian gap-43 compositions and methods of use